Original article
Women and mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-hispanic whites: The Corpus Christi Heart Project, 1988–1990

https://doi.org/10.1016/0895-4356(95)00572-2Get rights and content

Abstract

Mortality following myocardial infarction (MI) is greater among women than men and among Mexican Americans than non-Hispanic whites. Because therapy can affect mortality following MI, we examined differences in discharge therapy among these groups. Data regarding discharge therapy of 982 patients in the Corpus Christi Heart Project showed that women received fewer cardiovascular drugs than men, and Mexican Americans received fewer cardiovascular drugs than non-Hispanic whites. In multivariate analysis adjusting for age, cigarettes smoking, diabetes, hypertension, congestive heart failure, and serum cholesterol, the odds ratio for receipt of cardiovascular medications was 0.51 (95% CI: 0.28–0.93) for women versus men and 0.62 (0.3–1.15) for Mexican Americans versus non-Hispanic whites. Beta-blockers were prescribed rarely. Thus, treatment differences between ethnic and gender groups were observed following MI. Further research is needed to determine both the reasons for these differences and the extent to which these differences contribute to the observed survival patterns following MI.

References (42)

  • Effect of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril survival Study (CONSENSUS)

    N Engl J Med

    (1987)
  • The SOLVD Investigators

    Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

    N Engl J Med

    (1991)
  • JN Cohn et al.

    A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

    N Engl J Med

    (1991)
  • MH Alderman

    Prevention of myocardial infarction

    Am J Cardiol

    (1992)
  • Panel Expert

    Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults

    Arch Intern Med

    (1988)
  • JC LaRosa et al.

    The cholesterol facts: a summary of evidence relating dietary fats, serum cholesterol, and coronary heart disease: a joint statement by the American Heart Association and the National Heart, Lung and Blood Institute

    Circulation

    (1990)
  • National Research Council, Committee on Diet and Health
  • S Yusuf et al.

    Overview of results of randomized clinical trials in heart disease. II) Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification

    JAMA

    (1988)
  • G Rose et al.

    Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall Study

    Brit Med J

    (1986)
  • JE Rossouw et al.

    The value of lowering cholesterol after myocardial infarction

    N Engl J Med

    (1990)
  • MH Frick et al.

    Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary disease

    N Engl J Med

    (1987)
  • Cited by (42)

    • Addressing challenges faced by underrepresented biomedical investigators and efforts to address them: An NHLBI-PRIDE perspective

      2022, Journal of the National Medical Association
      Citation Excerpt :

      Health disparities may be due in part to disparities in access to care. For instance, Hispanic individuals were found to be less likely to receive cardiac medications after myocardial infarction,13 and discharge instructions.14 Black patients are less likely to have coronary artery bypass surgery,15 or receive care by a cardiologist when being treated for heart failure in the intensive care unit.16

    • Social vulnerability, medical care access and asthma related emergency department visits and hospitalization: An observational study

      2022, Heart and Lung
      Citation Excerpt :

      Although some physicians may show less care to low socioeconomic patients due to reduced reimbursement rates, others consider tailoring the treatment plan is the best way to ensure compliance and avoid financial or coverage issues.56-59 Akin to that, minority status showed similar disparities where African Americans found to have higher rates of undesirable procedures (e.g. amputations), perceived more negatively by pysicians, and higher overall mortality rates than Whites.54,60-66 Thus, this study is an important addition to emphasize that asthma-related intervention should go beyond clinical intervention and focus on studying existing disparity along with upstreaming populational level social determinants of health at research, policy, and implementational level.

    • 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation

      2009, Journal of the American College of Cardiology
      Citation Excerpt :

      Yet, most large, multicenter trials have not included sufficient numbers of women to allow conclusions about the efficacy and safety of their treatment. Several studies have documented a lower use of ACEIs in women with HF than in men (628), and another study reported that women are given fewer cardiovascular medications after an MI than men (564,629,630). These findings may explain why women have been noted to rate their quality of inpatient care lower than men and why they have less improvement in physical health status after an episode of HF (564).

    • Recent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of Hispanic and non-Hispanic white patients hospitalized with acute myocardial infarction: A population-based perspective

      2004, American Heart Journal
      Citation Excerpt :

      There was a marked increase in the hospital use of β-blockers over time in both race/ethnic groups. Underuse of β-blockers among Hispanics has been previously reported.2,24,26 In terms of the use of lipid-lowering therapy, our study suggests that Hispanics are slightly less likely to be treated with this regimen.

    View all citing articles on Scopus

    This investigation was supported by Grant Number HL38429, awarded by the National Heart, Lung, and Blood Institute, and by a grant awarded by the German Academic Exchange Service (DAAD), Bonn, Germany.

    View full text